About Foamix

Foamix develops innovative topical foam products for dermatology and gynecology.
The company partners with global pharmaceutical companies to create patent protected topical products with a variety of drugs including new chemical entities.
Advantages of Foamix foam products include increased permeability and drug delivery, convenient form of presentation preferred by users, and enhanced efficacy in clinical studies.

Read More

Minocycline Foam

For Acne, Rosacea and Skin Infections.
Acne Phase II reveals exceptional clinical results:
- Over 70% decrease in inflammatory lesions after 6 weeks
- 70% decrease in non–inflammatory lesions
- Highly preferred by patients over alternative drugs
- No drug related systemic side effects

 

Read More

Recent News

Feb 27

Foamix, Ltd., to Present at the 34th Annual Cowen & Company Health Care Conference -- Successful Phase 2 for First Ever Topical Minocycline for Acne and Impetigo

 Read more...
Aug 22

Foamix Celebrates Receiving Its TWENTIETH US Patent
Covers Unique Pharmaceutical Oil-Gel for Dermal and Ophthalmic Therapy

 Read more...